Related Experiment Videos
Deficiency of superoxide dismutase promotes cerebral vascular hypertrophy and vascular dysfunction in
Sanjana Dayal1, Gary L Baumbach2, Erland Arning3
1Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America.
Insights
Elevated superoxide contributes to cerebral vascular dysfunction and hypertrophy in hyperhomocysteinemia. This study reveals superoxide dismutase 1 (SOD1) deficiency exacerbates these effects, highlighting superoxide
Area of Science:
- Cardiovascular Research
- Neuroscience
- Vascular Biology
Background:
- Hyperhomocysteinemia is a known risk factor for cerebral vascular disease and ischemic stroke.
- The precise mechanisms linking hyperhomocysteinemia to cerebral vascular abnormalities are not fully understood.
- Superoxide's role in hyperhomocysteinemia-induced vascular damage requires further elucidation.
Purpose of the Study:
- To investigate the mechanistic role of superoxide in hyperhomocysteinemia-induced cerebral vascular dysfunction and hypertrophy.
- To utilize a genetic approach with superoxide dismutase 1 (SOD1)-deficient mice to assess superoxide's impact.
- To determine how altering superoxide levels affects cerebral arterioles under hyperhomocysteinemic conditions.
Main Methods:
- Employing a high methionine/low folate diet to induce hyperhomocysteinemia in wild-type and SOD1-deficient mice.
- Assessing endothelium-dependent vasodilation in cerebral arterioles.
- Quantifying vascular wall hypertrophy, including smooth muscle and elastin content, in pial arterioles.
Main Results:
- Hyperhomocysteinemic diet elevated superoxide levels and impaired vasodilation in wild-type mice.
- SOD1 deficiency exacerbated hyperhomocysteinemia-induced vascular dysfunction and hypertrophy.
- Significant increases in smooth muscle and elastin content were observed in SOD1-deficient mice subjected to the diet.
Conclusions:
- Superoxide is a critical mediator of cerebral vascular hypertrophy and vasomotor dysfunction in a model of dietary hyperhomocysteinemia.
- These findings provide mechanistic insights into how hyperhomocysteinemia contributes to cerebral vascular disease.
- Targeting superoxide may offer a therapeutic strategy for preventing stroke in hyperhomocysteinemic individuals.
Abstract:
There is an emerging consensus that hyperhomocysteinemia is an independent risk factor for cerebral vascular disease and that homocysteine-lowering therapy protects from ischemic stroke. However, the mechanisms by which hyperhomocysteinemia produces abnormalities of cerebral vascular structure and function remain largely undefined. Our objective in this study was to define the mechanistic role of superoxide in hyperhomocysteinemia-induced cerebral vascular dysfunction and hypertrophy. Unlike previous studies, our experimental design included a genetic approach to alter superoxide levels by using superoxide dismutase 1 (SOD1)-deficient mice fed a high methionine/low folate diet to produce hyperhomocysteinemia. In wild-type mice, the hyperhomocysteinemic diet caused elevated superoxide levels and impaired responses to endothelium-dependent vasodilators in cerebral arterioles, and SOD1 deficiency compounded the severity of these effects. The cross-sectional area of the pial arteriolar wall was markedly increased in mice with SOD1 deficiency, and the hyperhomocysteinemic diet sensitized SOD1-deficient mice to this hypertrophic effect. Analysis of individual components of the vascular wall demonstrated a significant increase in the content of smooth muscle and elastin. We conclude that superoxide is a key driver of both cerebral vascular hypertrophy and vasomotor dysfunction in this model of dietary hyperhomocysteinemia. These findings provide insight into the mechanisms by which hyperhomocysteinemia promotes cerebral vascular disease and ischemic stroke.